Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4749-4757

  Salgaller, Michael L ^a,b   Marincola, Francesco M ^a   Cormier, Janice N ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Northwest Biotherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ARTICLE; CANCER PATIENT; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MELANOMA; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; EPITOPES; FREUND'S ADJUVANT; HUMANS; IMMUNIZATION; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOCYTES; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS;

EID: 0029837404     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kawakami, Y., Eliyahu, S , Delgado, C. H., Robbins, P. F , Sakaguchi, K., Appella, E, Yannelli, J. R., Adema, G J , Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl. Acad. Sci. USA, 91: 6458, 1994.
2. Schild, H , Rötzschke, O., Kalbacher, H , and Rammensee, H-G. Limit of T cell tolerance to self proteins by peptide presentation. Science (Washington DC), 247: 1587, 1990
3. Vidard, L., Colarusso, L J , and Benacerraf, B. Specific T-cell tolerance may be preceded by a primary response. Proc Natl. Acad. Sci. USA. 91: 5627, 1994.
4. Ferber, I., Schonrich, G., Schenkel, J , Mellor, A. L., Hämmerling, G. J., and Arnold, B. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science (Washington DC), 263: 674, 1994
5. Aichele, P , Brduscha-Riem, K., Zinkernagel, R M., Hengartner, H., and Pircher, H T cell priming versus T cell tolerance induced by synthetic peptides J. Exp. Med., 182 261, 1995.
6. Salgaller, M. L., Afshar, A., Marincola, F. M., Rivoltini, L., Kawakami, Y., and Rosenberg, S A. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res., 55: 4972, 1995.
7. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R , Kast, W. M., Melief, C. J. M . Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., del Guercio, M-F., Southwood, S., Kubo, R. T , Chesnut, R. W., Grey, H M., and Chisari, F. V. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol, 153: 5586, 1994.
8. Chen, W., Khilko, S., Fecondo, J , Margulies, D. H., and McCluskey, J. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp. Med., 180: 1471, 1994
9. Sette, A , Sidney, J., del Guercio, M., Southwood, S., Ruppert, J , Dahlberg, C , Grey, H., and Kubo, R. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol., 31: 813, 1994.
10. Topalian, S L , Solomon, D., and Rosenberg, S. A. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol., 142: 3714, 1989.
11. Rosenberg, S. A., Lotze, M T, Muul, L. M , Chang, A. E., Avis, F P., Leitman, S., Linehan, W. M., Robertson, C. N , Lee, R E , Rubin, J. T., Seipp, C A., Simpson, C G., and White, D. E. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells, and interleukin-2 or high-dose interleukin-2 alone. N. Engl. J. Med., 316: 889, 1987.
12. Hopkins, K. A., van Leeuwen, A., Tardiff, G. N , and LeFor, W M Lymphotoxicity testing. In: A. A Zachery and G. A. Teseri (eds), ASHI Laboratory Manual. American Society for Histocompatibility and Immunogenetics, Lenexa, KS, 195, 1990.
13. Topalian, S L., Muul, L. M , Solomon, D., and Rosenberg, S. A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol Methods, 102: 127, 1987.
14. Hom, S. S., Schwartzentruber, D. J., Rosenberg, S A., and Topalian, S. L Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens J Immunol. Methods, 13: 18, 1993.
15. Utz, U., Koenig, S., Coligan, J. E , and Biddison, W. E. Presentation of three different viral peptides HTLV-1TAX, HCMV gB and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J. Immunol, 149: 214, 1992.
16. Cox, A. L , Skipper, J , Chen, Y., Henderson, R. A., Darrow, T. L , Shabanowitz, J., Engelhard, V. H., and Singluff, C. L , Jr. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines Science (Washington DC), 264: 716, 1994.
17. Kawakami, Y , Eliyahu, S , Sakaguchi, K , Robbins, P. F , Rivoltoni, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med., 180: 347, 1994
18. Kawakami, Y , Eliyahu, S., Jennings, C., Sakaguchi, K , Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154: 3961, 1995.
19. Bakker, A. B. H , Schreurs, M. W. J., de Boer, A. J , Kawakami, Y , Rosenberg, S. A , Adema, G J , and Figdor, C G Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med., 179: 1005, 1994.
20. Maas, R. A., Dullens, H. F. J., and Den Otter, W Interleukin-2 in cancer treatment: disappointing or (still) promising? Cancer Immunol. Immunother., 36: 141, 1993
21. Lipford, G. B., Bauer, S., Wagner, H , and Heeg, K. Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6 Immunology, 84: 298, 1995.
22. Morioka, N , Kikumoto, Y , Hoon, D. S. B., Morton, D. L., and Irie, R. F. A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patients. J. Immunol., 153 5650, 1994.
23. Livingston, P. O., Wong, G Y. C , Adluri, S , Tao, Y, Padavan, M., Parente, R , Hanlon, C., Jones-Calves, M., Helling, F., Ritter, G., Oettgen, H F., and Old, L. J. Improved survival in stage II melanoma patients with GM2 antibodies a randomized trial of adjuvant vaccination with GM2 ganglioside. J. Clin. Oncol., 12: 1036, 1994.
24. Lehner, P. J., Wang, E C. Y., Moss, P A. H., Williams, S., Platt, K., Friedman, S. M., Bell, J I , and Borysiewicz, L. K. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the v-beta-7 gene segment. J. Exp Med , 181: 79, 1995
25. Rivoltini, L , Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F M., Salgaller, M. L., Yannelli, J. R , Appella, E., and Rosenberg, S. A. Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with the human melanoma antigen MART-1 J. Immunol., 154: 2257, 1995.
26. Cheever, M A , Disis, M. L., Bernhard, H., Gralow, J. R., Hand, S. L., Huseby, E S., Qin, H L , Takahaski, M , and Chen, W. Immunity to oncogenic proteins. Immunol Rev., 145: 33, 1995.
27. McFarland, E J., Harding, P. A., Luckey, D , Conway, B , Young, R K., and Kurtizkes, D. R. High frequency of gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. J. Infect. Dis , 170: 766, 1994.
28. Mukherji, B., Chakraborty, N G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J. R., Kurtzman, S. K , Ergin, M. T., Meehan, J., and Mauri, F. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl Acad Sci. USA, 92: 8078, 1995.
29. Tsang, K. Y , Zaremba, S., Nieroda, C. A., Zhu, M. Z., Hamilton, J. M , and Schlom, J Generation of human cytotoxic T cells specific for human Carcinoembryonic Antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J. Natl Cancer Inst., 87: 982, 1995.